RedCo II Master Fund, L.P. — SEC Form 4 filings
SEC reporting owner CIK 1921783. 11 Form 4 filings on record with FilingPulse; latest filed 2026-04-23.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-09 to 2026-04-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 2 filings — 1,000,000 shares, $2,857,000 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 7 legs across 2 filings — 5,905,767 shares, $19,688,819 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 51.
- Largest priced transaction: sale of 2,634,506 shares @ $3.28 ($8,638,545) in ADC Therapeutics SA, filed 2026-04-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ADC Therapeutics SA (ADCT) | 10% owner | 8 | 6 legs · 1,000,000 sh · $2,857,000 | 7 legs · 5,905,767 sh · $19,688,819 | 34 |
| FATE THERAPEUTICS INC (FATE) | Director, 10% owner | 2 | — | — | 10 |
| Augmedix, Inc. (AUGX) | Director, 10% owner | 1 | — | — | 7 |
Form 4 filings — RedCo II Master Fund, L.P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-23 | 4/A | FATE THERAPEUTICS INC (FATE) jointly with Redmile Group, LLC, Green Jeremy | Other (J): 266,280 (derivative) @ $0 · Other (J): 266,280 (derivative) @ $0 | EDGAR |
| 2026-04-22 | 4 | FATE THERAPEUTICS INC (FATE) jointly with Redmile Group, LLC, Green Jeremy | Other (J): 8,977,624 @ $0 · Other (J): 8,977,624 @ $0 · Other (J): 3,691,324 (derivative) @ $0 · Other (J): 3,691,324 (derivative) @ $0 · Other (J): 266,280 (derivative) @ $0 · Other (J): 266,280 (derivative) @ $0 · +2 more | EDGAR |
| 2026-04-02 | 4 | ADC Therapeutics SA (ADCT) jointly with Redmile Group, LLC, Green Jeremy | Sale (S): 196,229 @ $3.75 · Sale (S): 188,407 @ $3.75 · Sale (S): 169,265 @ $3.80 · Sale (S): 162,517 @ $3.80 · Sale (S): 2,634,506 @ $3.28 · Sale (S): 2,529,491 @ $3.28 | EDGAR |
| 2025-10-28 | 4 | ADC Therapeutics SA (ADCT) jointly with Redmile Group, LLC, Green Jeremy | Purchase (P): 3,846,153 (derivative) @ $3.90 · Purchase (P): 3,846,153 (derivative) @ $3.90 | EDGAR |
| 2025-06-13 | 4 | ADC Therapeutics SA (ADCT) jointly with Redmile Group, LLC, Green Jeremy | Purchase (P): 15,734,267 (derivative) @ $3.43 · Purchase (P): 12,465,234 (derivative) @ $3.43 | EDGAR |
| 2024-12-13 | 4 | ADC Therapeutics SA (ADCT) jointly with Redmile Group, LLC, Green Jeremy | Purchase (P): 50,000 @ $2.28 · Purchase (P): 50,000 @ $3.81 · Purchase (P): 50,000 @ $2.28 · Purchase (P): 50,000 @ $3.81 | EDGAR |
| 2024-12-06 | 4 | ADC Therapeutics SA (ADCT) jointly with Redmile Group, LLC, Green Jeremy | Sale (S): 25,352 @ $2.07 · Other (J): 50,672 @ $2.07 · Other (J): 50,672 @ $2.07 · Other (J): 50,672 @ $2.07 · Other (J): 26,656 (derivative) @ $2.07 · Other (J): 26,656 (derivative) @ $2.07 · +1 more | EDGAR |
| 2024-10-04 | 4 | Augmedix, Inc. (AUGX) jointly with Redmile Group, LLC, Green Jeremy, Redmile Private Investments II, L.P. | Disposition to issuer (D): 16,421,788 @ $2.35 · Disposition to issuer (D): 9,446,146 @ $2.35 · Disposition to issuer (D): 6,218,238 @ $2.35 · Disposition to issuer (D): 3,125,195 (derivative) · Disposition to issuer (D): 3,125,195 (derivative) · Disposition to issuer (D): 1,093,799 (derivative) · +1 more | EDGAR |
| 2024-07-03 | 4 | ADC Therapeutics SA (ADCT) jointly with Redmile Group, LLC, Green Jeremy | Purchase (P): 400,000 @ $2.81 · Purchase (P): 400,000 @ $2.81 | EDGAR |
| 2024-05-10 | 4 | ADC Therapeutics SA (ADCT) jointly with Redmile Group, LLC, Green Jeremy | Purchase (P): 6,107,181 (derivative) @ $4.81 · Purchase (P): 8,163,265 (derivative) @ $4.81 | EDGAR |
| 2024-02-09 | 4 | ADC Therapeutics SA (ADCT) jointly with Redmile Group, LLC, Green Jeremy | Purchase (P): 56,900 (derivative) · Other (J): 59,986 (derivative) @ $1.68 · Purchase (P): 28,652 (derivative) · Purchase (P): 50,000 (derivative) · Purchase (P): 100,000 (derivative) · Purchase (P): 100,000 (derivative) · +16 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1921783 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →